These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 29573771)

  • 41. Avastin and diode laser: a combined modality in managing epistaxis in hereditary hemorrhagic telangiectasia.
    Marglani OA; Bawazeer NA; Abu Suliman OA
    Am J Otolaryngol; 2013; 34(5):603-5. PubMed ID: 23541684
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of severe refractory epistaxis in hereditary hemorrhagic telangiectasia using a two-flap nasal closure method.
    Timmins BH; Hunter BN; Wilson KF; Ward PD
    Int Forum Allergy Rhinol; 2016 May; 6(5):544-8. PubMed ID: 26751606
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel treatment for patients with hereditary haemorrhagic telangiectasia.
    Farnan TB; Gallagher G; Scally CM
    J Laryngol Otol; 2002 Oct; 116(10):849-50. PubMed ID: 12437844
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A natural obturator in hereditary haemorrhagic telangiectasia.
    Soni-Jaiswal A; Woolford TJ
    J Laryngol Otol; 2009 Jun; 123(6):695-6. PubMed ID: 19275781
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Septectomy and septal dermoplasty for the treatment of severe transfusion-dependent epistaxis in patients with hereditary hemorrhagic telangiectasia and septal perforation.
    Lesnik GT; Ross DA; Henderson KJ; Joe JK; Leder SB; White RI
    Am J Rhinol; 2007; 21(3):312-5. PubMed ID: 17621815
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hereditary hemorrhagic telangiectasia with liver cirrhosis: a case report.
    Xu L; Xu F; Wang Q; Ke X
    BMC Gastroenterol; 2021 Sep; 21(1):343. PubMed ID: 34488642
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epistaxis due to hereditary hemorrhagic telangiectasia.
    Zohar Y; Strauss M
    Laryngoscope; 1995 Apr; 105(4 Pt 1):445-6. PubMed ID: 7794350
    [No Abstract]   [Full Text] [Related]  

  • 48. The use of thalidomide therapy for refractory epistaxis in hereditary haemorrhagic telangiectasia: systematic review.
    Harrison L; Kundra A; Jervis P
    J Laryngol Otol; 2018 Oct; 132(10):866-871. PubMed ID: 30191780
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinical 22-case study of hereditary hemorrhagic telangiectasia subjects undergoing nasal dermoplasty].
    Kikuchi H; Imayoshi S; Yamauchi T; Ichimura K
    Nihon Jibiinkoka Gakkai Kaiho; 2012 Feb; 115(2):108-11. PubMed ID: 22568130
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The impact of septodermoplasty and potassium-titanyl-phosphate (KTP) laser therapy in the treatment of hereditary hemorrhagic telangiectasia-related epistaxis.
    Harvey RJ; Kanagalingam J; Lund VJ
    Am J Rhinol; 2008; 22(2):182-7. PubMed ID: 18416977
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intermittent low-dose bevacizumab in hereditary hemorrhagic telangiectasia : A case report.
    Huemer F; Dejaco M; Grabmer C; Melchardt T; Neureiter D; Mayer G; Egle A; Greil R; Weiss L
    Wien Klin Wochenschr; 2017 Feb; 129(3-4):141-144. PubMed ID: 27878613
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Bilateral closure of the nasal cavity. An original surgical technique of treatment of severe recurrent epistaxis in Rendu-Osler disease].
    Serrano E; Percodani J; Pessey JJ
    Ann Otolaryngol Chir Cervicofac; 1998 Jun; 115(3):169-73. PubMed ID: 9765720
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Surgical management of epistaxis in hereditary hemorrhagic telangiectasia.
    Zohar Y; Sadov R; Shvili Y; Talmi Y; Laurian N
    Arch Otolaryngol Head Neck Surg; 1987 Jul; 113(7):754-7. PubMed ID: 3580157
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and safety of thalidomide for the treatment of severe recurrent epistaxis in hereditary haemorrhagic telangiectasia: results of a non-randomised, single-centre, phase 2 study.
    Invernizzi R; Quaglia F; Klersy C; Pagella F; Ornati F; Chu F; Matti E; Spinozzi G; Plumitallo S; Grignani P; Olivieri C; Bastia R; Bellistri F; Danesino C; Benazzo M; Balduini CL
    Lancet Haematol; 2015 Nov; 2(11):e465-73. PubMed ID: 26686256
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The utility of bipolar electrocautery in hereditary hemorrhagic telangiectasia.
    Ghaheri BA; Fong KJ; Hwang PH
    Otolaryngol Head Neck Surg; 2006 Jun; 134(6):1006-9. PubMed ID: 16730547
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Argon plasma coagulation is an effective treatment for hereditary hemorrhagic telangiectasia patients with severe nosebleeds.
    Pagella F; Matti E; Chu F; Pusateri A; Tinelli C; Olivieri C; Canzonieri C; Boeri L; Ornati F; Danesino C
    Acta Otolaryngol; 2013 Feb; 133(2):174-80. PubMed ID: 23066781
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thalidomide for Epistaxis in Patients with Hereditary Hemorrhagic Telangiectasia: A Preliminary Study.
    Fang J; Chen X; Zhu B; Ye H; Zhang W; Guan J; Su K
    Otolaryngol Head Neck Surg; 2017 Aug; 157(2):217-221. PubMed ID: 28418273
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Control of epistaxis in patients with hereditary hemorrhagic telangiectasia.
    Siegel MB; Keane WM; Atkins JF; Rosen MR
    Otolaryngol Head Neck Surg; 1991 Nov; 105(5):675-9. PubMed ID: 1754250
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Endoscopic intranasal dermoplasty for the treatment of severe transfusion-dependent epistaxis in patients with hereditary hemorrhagic telangiectasia].
    He MQ; Liu YQ; Xu T
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Sep; 43(9):703-4. PubMed ID: 19035267
    [No Abstract]   [Full Text] [Related]  

  • 60. Worsening of nose bleeding heralds high cardiac output state in hereditary hemorrhagic telangiectasia.
    Khalid SK; Pershbacher J; Makan M; Barzilai B; Goodenberger D
    Am J Med; 2009 Aug; 122(8):779.e1-9. PubMed ID: 19635281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.